Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
Severity: Warning
Message: include(../assets/text/seoInfo/5384200.txt): Failed to open stream: No such file or directory
Filename: include/seoInfo.php
Line Number: 77
Backtrace:
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: _error_handler
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: include
File: /var/www/html/application/views/include/product/indexNew.php
Line: 1266
Function: include
File: /var/www/html/application/views/commonNew.php
Line: 442
Function: include
File: /var/www/html/application/controllers/Search.php
Line: 1720
Function: view
File: /var/www/html/index.php
Line: 224
Function: require_once
Severity: Warning
Message: include(): Failed opening '../assets/text/seoInfo/5384200.txt' for inclusion (include_path='.:/usr/share/pear:/usr/share/php')
Filename: include/seoInfo.php
Line Number: 77
Backtrace:
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: _error_handler
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: include
File: /var/www/html/application/views/include/product/indexNew.php
Line: 1266
Function: include
File: /var/www/html/application/views/commonNew.php
Line: 442
Function: include
File: /var/www/html/application/controllers/Search.php
Line: 1720
Function: view
File: /var/www/html/index.php
Line: 224
Function: require_once
A Midazolam Maleate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Midazolam Maleate, including repackagers and relabelers. The FDA regulates Midazolam Maleate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Midazolam Maleate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Midazolam Maleate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Midazolam Maleate supplier is an individual or a company that provides Midazolam Maleate active pharmaceutical ingredient (API) or Midazolam Maleate finished formulations upon request. The Midazolam Maleate suppliers may include Midazolam Maleate API manufacturers, exporters, distributors and traders.
click here to find a list of Midazolam Maleate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Midazolam Maleate DMF (Drug Master File) is a document detailing the whole manufacturing process of Midazolam Maleate active pharmaceutical ingredient (API) in detail. Different forms of Midazolam Maleate DMFs exist exist since differing nations have different regulations, such as Midazolam Maleate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Midazolam Maleate DMF submitted to regulatory agencies in the US is known as a USDMF. Midazolam Maleate USDMF includes data on Midazolam Maleate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Midazolam Maleate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Midazolam Maleate suppliers with USDMF on PharmaCompass.
A Midazolam Maleate written confirmation (Midazolam Maleate WC) is an official document issued by a regulatory agency to a Midazolam Maleate manufacturer, verifying that the manufacturing facility of a Midazolam Maleate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Midazolam Maleate APIs or Midazolam Maleate finished pharmaceutical products to another nation, regulatory agencies frequently require a Midazolam Maleate WC (written confirmation) as part of the regulatory process.
click here to find a list of Midazolam Maleate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Midazolam Maleate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Midazolam Maleate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Midazolam Maleate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Midazolam Maleate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Midazolam Maleate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Midazolam Maleate suppliers with NDC on PharmaCompass.
Midazolam Maleate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Midazolam Maleate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Midazolam Maleate GMP manufacturer or Midazolam Maleate GMP API supplier for your needs.
A Midazolam Maleate CoA (Certificate of Analysis) is a formal document that attests to Midazolam Maleate's compliance with Midazolam Maleate specifications and serves as a tool for batch-level quality control.
Midazolam Maleate CoA mostly includes findings from lab analyses of a specific batch. For each Midazolam Maleate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Midazolam Maleate may be tested according to a variety of international standards, such as European Pharmacopoeia (Midazolam Maleate EP), Midazolam Maleate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Midazolam Maleate USP).
LOOKING FOR A SUPPLIER?
